Walentyna B.
- Country
- Poland
- Department
- #2401: Klinika Onkologii i Hematologii Dziecięcej
Research Overview
Data & Insights
Has run more than one trial at 0 of 19 partner sites.
Specializations
Pediatric Oncology
The investigator specializes in treating young patients with acute myeloid leukemia (AML), particularly focusing on cases involving FLT3 mutations. Their research interest centers on developing targeted therapeutic approaches for pediatric blood cancers.
- Pediatric AML Treatment
- FLT3-Mutated Leukemia
- Targeted Therapy Approaches
Their expertise extends to combination therapy strategies incorporating novel targeted agents with conventional chemotherapy protocols.
Precision Medicine
The investigator focuses on personalized treatment approaches based on specific genetic mutations. Their work emphasizes the importance of molecular diagnostics in guiding therapeutic decisions for pediatric cancer patients.
- Molecular-Based Treatment
- Genetic Mutation Analysis
- Personalized Therapy Protocols
Their research contributes to advancing targeted treatments in pediatric oncology through mutation-specific therapeutic strategies.
Clinical Pharmacology
The investigator has developed expertise in pediatric drug development and pharmacokinetics, particularly in the context of targeted therapies for blood cancers.
- Drug Safety Assessment
- Pharmacological Monitoring
- Therapeutic Drug Optimization
Their work involves evaluating drug safety and efficacy in pediatric populations, with particular attention to age-specific dosing considerations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.